CA2683015A1 - Compositions de cicatrisation contenant des biomateriaux keratiniques - Google Patents

Compositions de cicatrisation contenant des biomateriaux keratiniques Download PDF

Info

Publication number
CA2683015A1
CA2683015A1 CA002683015A CA2683015A CA2683015A1 CA 2683015 A1 CA2683015 A1 CA 2683015A1 CA 002683015 A CA002683015 A CA 002683015A CA 2683015 A CA2683015 A CA 2683015A CA 2683015 A1 CA2683015 A1 CA 2683015A1
Authority
CA
Canada
Prior art keywords
keratin derivative
kerateine
keratose
keratin
consists essentially
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002683015A
Other languages
English (en)
Other versions
CA2683015C (fr
Inventor
Mark E. Van Dyke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wake Forest University Health Sciences
Original Assignee
Wake Forest University Health Sciences
Mark E. Van Dyke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wake Forest University Health Sciences, Mark E. Van Dyke filed Critical Wake Forest University Health Sciences
Publication of CA2683015A1 publication Critical patent/CA2683015A1/fr
Application granted granted Critical
Publication of CA2683015C publication Critical patent/CA2683015C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
CA2683015A 2007-04-17 2008-04-17 Compositions de cicatrisation contenant des biomateriaux keratiniques Active CA2683015C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91226507P 2007-04-17 2007-04-17
US60/912,265 2007-04-17
PCT/US2008/004984 WO2008130607A2 (fr) 2007-04-17 2008-04-17 Compositions de cicatrisation contenant des biomatériaux kératiniques

Publications (2)

Publication Number Publication Date
CA2683015A1 true CA2683015A1 (fr) 2008-10-30
CA2683015C CA2683015C (fr) 2016-11-08

Family

ID=39876125

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2683015A Active CA2683015C (fr) 2007-04-17 2008-04-17 Compositions de cicatrisation contenant des biomateriaux keratiniques

Country Status (7)

Country Link
EP (1) EP2146738A2 (fr)
JP (1) JP5868592B2 (fr)
CN (1) CN101730540A (fr)
AU (1) AU2008241396B2 (fr)
CA (1) CA2683015C (fr)
IL (1) IL201425A0 (fr)
WO (1) WO2008130607A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011109808A1 (fr) * 2010-03-05 2011-09-09 Wake Forest University Health Sciences Système d'administration contrôlée
AU2011329839B2 (en) 2010-11-17 2016-12-08 Wake Forest University Health Sciences Keratin compositions for treatment of bone deficiency or injury
EP3412683B1 (fr) 2011-08-17 2022-02-09 KeraNetics, Inc. Procédés d'extraction de protéines de kératine
CA2845267C (fr) 2011-08-17 2021-07-06 Keranetics Llc Compositions gelifiantes a faible concentration en proteines
US9827245B2 (en) 2013-03-15 2017-11-28 KeraNetics, LLC Keratin compositions comprising halofuginone
CN106470649A (zh) 2014-06-04 2017-03-01 兹姆生物科学公司 用于改善皮肤质量的组合物和方法
JP6637241B2 (ja) * 2015-03-02 2020-01-29 アドバンス株式会社 可溶性ケラテインの製造法
CN106473945A (zh) * 2016-07-21 2017-03-08 北京东方艾美生物技术股份有限公司 一种角蛋白面膜的制备方法
JPWO2018220739A1 (ja) * 2017-05-31 2020-08-13 株式会社 リトル・サイエンティスト 高収率で得られるケラチン誘導体とその使用方法
CN112794894B (zh) * 2019-10-28 2023-09-26 中国医学科学院药物研究所 一种角蛋白bd-17、制法和其药物组合物与用途
CN112724227B (zh) * 2019-10-28 2023-09-26 中国医学科学院药物研究所 一种角蛋白bd-1、制法和其药物组合物与用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4570629A (en) * 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
CA1213520A (fr) * 1982-03-17 1986-11-04 Abe Widra Copolyelectrolytes biopolymeres hydrophiles, et pansements biodegradables qui les renferment
FR2661414B1 (fr) * 1990-04-25 1995-03-24 Michel Jean Pierre Produit a base de keratines modifiees, son procede de preparation et les applications notamment en medecine humaine ou veterinaire.
US6270791B1 (en) * 1999-06-11 2001-08-07 Keraplast Technologies, Ltd. Soluble keratin peptide
US6270793B1 (en) * 1999-09-13 2001-08-07 Keraplast Technologies, Ltd. Absorbent keratin wound dressing
US6544548B1 (en) * 1999-09-13 2003-04-08 Keraplast Technologies, Ltd. Keratin-based powders and hydrogel for pharmaceutical applications
US6371984B1 (en) * 1999-09-13 2002-04-16 Keraplast Technologies, Ltd. Implantable prosthetic or tissue expanding device
NZ534919A (en) * 2002-01-28 2006-08-31 Keraplast Tech Ltd Bioactive keratin peptides
DK1495048T3 (da) * 2002-04-10 2014-05-05 Keraplast Tech Ltd Heterogene proteinnetværk, som er tværbundet med silikone-indeholdende forbindelser, og fremgangsmåder til fremstilling af disse
AU2007217898A1 (en) * 2006-02-17 2007-08-30 Wake Forest University Health Sciences Coatings and biomedical implants formed from keratin biomaterials

Also Published As

Publication number Publication date
AU2008241396A1 (en) 2008-10-30
CA2683015C (fr) 2016-11-08
WO2008130607A2 (fr) 2008-10-30
EP2146738A2 (fr) 2010-01-27
CN101730540A (zh) 2010-06-09
IL201425A0 (en) 2010-05-31
JP5868592B2 (ja) 2016-02-24
AU2008241396B2 (en) 2014-06-19
WO2008130607A3 (fr) 2009-02-26
JP2010524943A (ja) 2010-07-22

Similar Documents

Publication Publication Date Title
US8258093B2 (en) Wound healing compositions containing keratin biomaterials
EP1991256B1 (fr) Compositions contenant des biomatériaux à base de kératine, destinées à induire la coagulation et la guérison
CA2683015C (fr) Compositions de cicatrisation contenant des biomateriaux keratiniques
Vasconcelos et al. The use of keratin in biomedical applications
EP0322249B1 (fr) Méthodes de préparation et compositions pharmaceutiques contenant des dérivés du collagène
EP0804257B1 (fr) Materiau du type feuille autonome compose de fibrine reticulee, destine a prevenir les adherences postoperatoires
WO1996040033A1 (fr) Timbre hemostatique non biologique
ES2216323T3 (es) Medicina para promover la cicatrizacion y que contiene trombocitos.
JP2002511489A (ja) 液体媒体中の天然コラーゲンを滅菌する方法、得られた滅菌天然コラーゲン、それを含む組成物及びその使用
WO2013025940A1 (fr) Angiogenèse induite par l'alpha-kératose
Santhanam et al. Bovine based collagen dressings in wound care management
CN110292653B (zh) 一种具有抑菌功效的胶原基纳米复合止血材料及其制备方法
CN113194965A (zh) 用于治疗伤口的药物组合物
RU2789304C1 (ru) Биоразлагаемая ранозаживляющая пленка
JPH0720873B2 (ja) 創傷治癒剤
Mazumder et al. A NEW INNOVATION OF KERATIN BASED DRESSING IN SKIN WOUND HEALING AND TISSUE REGENERATION
Zidan et al. EFFICACY OF AMNION AND PRP FOR TREATMENT OF EXPERIMENTALLY INDUCED WOUNDS IN DISTAL EQUINE LIMBS
Ghafar et al. In vivo application of Oreochromis niloticus scales collagen as alternative wound healing therapy
MXPA00009733A (en) Method for sterilising native collagen in liquid medium, resulting native collagen, compositions containing same and uses

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130404